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Mariana Calderon, Guillermo Castorena and Emina Pasic  
Hospital Medica Sur, 
Universidad Nacional Autonoma de Mexico UNAM, 
Mexico 
1. Introduction 
Surgery is often physically and psychologically stressful and in the postoperative period, 
many patients experience significant amounts of pain and discomfort. The International 
Association for the Study of Pain defines pain as “an unpleasant sensory and emotional 
experience associated with actual or potential damage, or described in terms of such 
damage”.  
Although acute pain and associated responses can be unpleasant and often debilitating, they 
serve important adaptive purposes. They identify and localize noxious stimuli, initiate 
withdrawal responses that limit tissue injury, inhibit mobility thereby enhancing wound 
healing1. Nevertheless, intense and prolonged pain transmission2, as well as analgesic 
undermedication, can increase surgical postsurgical / traumatic morbidity, delay recovery, 
and lead to development of chronic pain. Despite the obviously simple nature of surgical 
incision, however, perioperative and specifically postoperative pain remain underevaluated 
and poorly treated. Recent surveys suggest that 80% of patients experience pain after 
surgery3, 11% having severe pain, and that pain delays recovery in 24% of patients 
undergoing ambulatory surgery4. 
2. Pathophisiology of acute pain 
A number of theories have been formulated to explain noxious perception: The specificity 
theory by Descartes, the intensity theory by Sydenham, and recently the gate control theory 
by Melzack and Wall where they suggested that sensory fibers of differing specificity 
stimulate second-order spinal neurons fire at a different intensity.5 Pain perception is 
dependent on the degree of noxious stimulation, local descending inhibition from CNS 
centers, and responses of second order transmissions cells. Woolf and coworkers have 
proposed a new theory to explain pain-processing, suggesting that primary and secondary 
hyperalgesia as well as qualitative differences among physiologic, inflammatory, and 
neuropathic pain reflect sensitization of both peripheral nociceptors and spinal neurons. 
Noxious perception is the result of several distinct processes that begin in the periphery, 
extended up the neuraxis, and terminate at supraspinal regions responsible for 
interpretation and reaction. 6 
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Pain can only be experienced when nociceptive afference reaches the cortex. Most brain 
imaging studies report an activation of the sensory and affective brain structures following a 
nociceptive stimulus, demonstrating that pain perception is a complex experience with 
emotion, cognitive factors, and previous experience playing an important role in perceived 
pain. It can therefore be understood why the clinician should address pain from both the 
physical as well the emotional aspect.  
Injured tissues will release various substances, such as potassium, prostaglandins, 
histamine, of bradykinins that are pronociceptive, and will also evoke an immune response. 
7These inflammatory and immune factors will sensitize the nociceptive receptors directly 
within the lesion and in the surrounding neurons. Primary hyperalgesia, which follows the 
release of these factors, may be measured as a lowered pain threshold in and around the 
lesion.  
The most important fibers in the transmission of nociceptive stimulus are the Aδ and C 
fibers. The first ones will rapidly transmit a brief and acute pinprick-like sensation, 
perceived to be precisely located at the point of stimulation. Following this activity, C fibers 
will transmit their information with a relatively long delay (100 millisenconds to a second, 
depending on the stimulus location). This second sensory input results in a more diffuse 
deep pain sensation. 8 
Secondary hyperalgesia is a phenomenon that refers to sensitization that occurs within the 
central nervous system9. Repeated recruitment of C-fibers following an injury will produce 
central sensitization by changing the respose properties of the membranes of secondary 
neurons. This will result in an increase of the firing rate, a phenomenon known as windup10. 
The high frequency recruitment of C fibers, either by increased repetitive stimuli or by a tonic 
stimulation11, will induce an increase of the perceived pain, even if the intensity of the 
stimulation remains constant. The spinal sensitization can persist for minutes, but can also be 
present for hours and even days12. The prolonged activation of the NMDA receptors will 
induce the transcription of rapidly expressed genes (c-fos, c-jun), resulting in sensitization of 
nociceptors. This neuronal plasticity of the secondary neuron will result in a reduced threshold 
in the spinal cord, producing hyperalgesic and allodynic responses that may persist even after 
the healing of the injury. Considering the impact of sensitization, an aggressive and early 
treatment plan to reduce pain will help in preventing ongoing chronic pain6. 
After reviewing some of the above mentioned theories, we can conclude that pain is a 
dynamic phenomenon; all the nociceptive signals will be modulated at all levels from the 
periphery to the brain but we still have to take into account genetic and environmental 
factors that will influence the acute perception and the development of persistent pain. 
Understanding the neurophysiologic mechanisms involved in the development and 
maintenance of pain will help the clinician to devise a more effective treatment plan.  
3. Risk factors for developing chronic pain 
Three factors have been proposed to play a role in the chronicity of pain: personal 
predisposition, environmental factors, and psychologic factors.  
It is also well known that chronic pain syndromes more frequently affect women than men; 
the reason for this predisposition is probably multifactorial, with sex hormones likely 
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playing an important role. The age is also a factor in this sort of patients; literature suggests 
that in the 50s it begins a reduction in endogenous pain control which contributes to the 
higher prevalence of chronic pain in the older population. Expectations of pain, which has 
not previously been experienced, may confound pain memory, especially when anxiety 
levels are high. Hysterectomy procedure is a high-risk surgery in terms of psychological and 
environmental ambience for most of the patients where the surgical team must be aware of 
these factors.  
4. Physiology and anatomy of pain in hysterectomy 
Uterine innervation stems from a variety of sources. Parasympathetic nerves stemming from 
S2 to S4 conglomerate into the cervical ganglion of Frankenhauser. Sympathetic nerves, the 
predominant influence in uterine innervation, descend from T7-T8 to the internal iliac plexi 
bilaterally to meet their parasympathetic counterparts. Together these nerves innervate not 
only the uterus, but also the bladder and upper vagina. Within the uterus nerves terminate 
both within muscle fibers and the endometrium itself. The perineum is innervated by the 
pudendal nerve, which also enters the spinal cord at the S2-S4 levels. 
Although these systems are primarily responsible for the function of the uterus, the 
perception of pain stems from different sites. Visceral afferent fibers from the uterine corpus 
transmit pain signals to the brain by entering the spinal cord at the T11-T12 levels, whereas 
spinal cord levels S2-S4 receive signals from the cervis, vagina, and perineum. Recognition 
of this divergence is the key13, because of the pain fibers’ high entry point in the spinal cord 
the block of lower stems will be insufficient for relieving pain independently of the type of 
surgery (laparoscopic vs open procedure). 
Recent advances in minimally invasive surgery have made procedures to be less traumatic 
however abdominal pain must be avoided because it can restrict ventilation and prevent 
ambulation; this statement is particularly important in the obese population.14 
5. Mechanistic approach to pain treatment 
The different types of pain may be divided into two categories: nociceptive and neurogenic. 
Acute postoperative pain relies in the nociceptive category where there is a transitory 
response to nociceptive stimuli that could be mechanical, thermal or chemical. Nociceptive 
pain plays an important protective role and is normally present for as long as the protection 
of the organism in necessary; however if not treated well it will persist even after healing of 
the initial injury. 
Postoperative pain management is based on a number of principles. Pain prevention is 
preferable to, and more efficacious than, treatment of established pain15. Multimodal 
analgesia is a rational approach to pain management and is more effective. The aim of 
multimodal analgesia combinations is to reduce postoperative pain. Theoretically, 
multimodal analgesia is achieved by a combination of opioids, and regional blocks, which 
attenuate the pain-related signals in the central nervous system, and nonsteroidal anti-
inflammatory drugs, which act mainly in the periphery to inhibit the initiation of pain 
signals.  
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Abdominal hysterectomy is refered among the most frequently procedures associated to 
pain in the gynecologic population.16 
Whether is an open or laparoscopic procedure, abdominal or vaginal approach, the clinician 
has many options for providing multimodal analgesia: patient control analgesia, epidural 
analgesia, intratecal opioids, wound infiltration, nonsteroidal anti-inflammatory drugs and 
adjuvant drugs. 
5.1 Nonselective nonsteroidal anti-inflammatory drugs, COX-2 inhibitors, and 
acetaminophen 
Nonsteroidal anti-inflammatory drugs (NSAIDs) form a heterogeneous group of organic 
acids that have analgesic, antipyretic, anti-inflammatory, and platelet inhibitory actions.  
NSAIDs have long been used in the treatment of nonoperative pain syndromes; their 
mechanism of action is through the nonspecific inhibition of COX, which therefore blocks 
both the constitutive COX-1 isoform, responsible for gastric protection and platelet function, 
and the inducible proinflamatory isoform, COX-2. Thus, the actions of the NSAIDs result in 
both the desired analgesic effects and the unwanted adverse effects of the COX isoforms. 
Some systematic reviews have concluded that there are no significant differences in the 
analgesic efficacy between different NSAIDs, but they do have different levels of toxicities, 
especially at high or increased doses17. The use of the NSAIDs in preemptive analgesic 
therapy has been debated and is still controversial with non measurable long-term 
advantage when compared with its postoperative use18 
The postoperative use of NSAIDs has been evaluated in several types of surgical procedures 
and in several dosages forms either as a single therapy compared with other analgesics or 
placebo or in a multimodal approach in combination with different kinds of analgesics to 
determine their efficacy, opiate-sparing effects and safety. One example is the postoperative 
use of ketorolac in combination with tramadol in patients who underwent abdominal 
surgery; the use of this combination was found to be safe and effective with similar pain 
relief when compared to a higher dose of tramadol used as monotherapy19 
In another study a group of patients with open gynecologic surgery, received a loading dose 
of parecoxib on day one and continued their analgesic regimen with morphine through a 
PCA. After day one they were separated in two groups: placebo vs parecoxib 20mg twice 
daily on days 2-5. The results were that in the parecoxib treatment group, 24-hour summed 
pain intensity scores were significantly lower than in the placebo treatment group on days 2 
and 3 and consumed less rescue medication compared with the placebo-treated patients20 
In an effort to minimize the risk of bleeding and the risk of gastrointestinal complications 
that have traditionally been associated with the use of the nonselective NSAIDs, the use of 
COX-2 inhibitors as non opioid adjuvants has become increasingly popular to reduce pain 
during the perioperative period21. They haven’t shown increased analgesic potency in the 
treatment of postoperative pain; even more valdecoxib was not approved by the US FDA for 
the management of acute pain. Actually valdecoxib and rofecoxib were voluntarily 
withdrawn from the market because of concerns of increasing the risk of cardiovascular 
events. 
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Unless there is a major contraindication for the use of the NSAIDs, they are generally 
accepted for the management of mild to moderate postoperative pain and as adjuncts for 
use with other analgesics in moderate to severe postoperative pain (table 1). The 
concomitant inhibition of physiological COX-1 leads to renal toxicity, platelet dysfunction, 
and gastrointestinal toxicity. 
 COX Selectivity COX-2:COX-1 ratio Vd 
(I) 
T1/2 β 
(h) 
Clearance 
(I h-1) 
Ibuprofen None 1:1 10 2.4 4.4 
Diclofenac None 1:1 30 2 15.6 
Ketorolac None 1:1 14 5.4 2.3 
Meloxicam Moderate 10-13:1 10-15 20-22 0.5 
Celecoxib High 375:1 400 11 30 
Rofecoxib High >800:1 86 17 7.2 
Table 1. Preparing for the primary FRCA, Non-steroidal anti-inflammatory drugs, Sharpe P. 
and Thompson J.  
Bulletin 6. The Royal College of Anaesthetists, March 2001 
The group of patients who are at higher risk of adverse reactions when treated with NSAIDs 
are well known; they include the elderly, pregnant women (and their fetuses), neonates, 
patients with liver, kidney, or cardiac disorders, and those with hypertension, multiple 
myeloma, peptic disorders, or active rheumatoid arthritis.  
The dosage of any NSAIDs must be according to specific recommendations and prescribing 
practices. It is well known that many of the medication errors in the hospital setting are due 
to analgesic overdose and misused16.  
5.2 Acetaminophen (paracetamol) 
Acetaminophen was first used in 1883 but gained widespread acceptance only after 1948. It 
possesses a wide safety profile. The WHO has recommended it to be used as the first line 
medication for mild, moderate, or severe pain and to add opioids and other analgesics as the 
pain remains persistent or increases. This multimodal approach has been adopted in the 
European Union and has effectively resulted in a 33% decrease in opioids use and their 
adverse effects. 
Although paracetamol is acceptably safe in usual dosages, there have been some reports that 
in patients with significant hepatic dysfunction or those taking substances that induce 
hepatic enzymes even common doses may aggravate liver dysfunction, sometimes to the 
point of causing hepatic failure. Stable mild chronic liver disease does not seem to be a 
contraindication.22  
Paracetamol is one of the most commonly ingested medications in deliberate self-poisoning 
and accidental ingestion by children. The problem of overdosage is substantial. Fulminant 
hepatic failure occurs in 1-5% of cases of paracetamol overdosage 3-6 days after ingestion23 
with frequent deaths in people who take 20-25g. There is noly a narrow margin betwwn the 
normal maxium 24-hour dosage and that which can cause liver damage and acute hepatic 
failure.  
Available in oral, rectal and intravenous administration (most of the countries) 
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5.3 Opioids 
Opioids represent a class of analgesics that provide powerful dose-dependent pain relief for 
patients suffering moderate to severe pain. This class of drug includes a large number of 
compounds with variable pharmacokinetics and pharmacodynamics and a dosing 
versatility for its administration. 
Opioids interact with specific transmembrane G-protein coupled binding sites termed opiate 
or opioid receptors. These receptors are located primarily in the spinal dorsal horn, central 
gray, medial thalamus, amygdala, limbic cortex, and other regions of the central nervous 
system that process affective and suffering aspects of pain perception24. Opioid receptors 
serve as binding sites for endogenous ligands, including endorphins and the enkephalins, 
which naturally modulate pain transmission and perception. Opiates ad synthetic opioids 
have structural/chemical similarities that enable them to bind and activate opioid receptors 
resulting in powerful, dose-dependent analgesia25 
Three principal opioid receptor subtypes, designated as μ, κ and δ have been isolated and 
characterized. μ receptor (also known as OPR1) is the main responsible for the analgesic and 
side effects of opiates; its primary agonist includes β-endorphin and morphine.26 
According to their binging affinities and intrinsic activity at receptor subtypes, opioids are 
classified as agonists, partial agonists, mixed agonist-antagonists, and complete 
antagonists17,18. (tables 2 and 3) 
Opiates 
Agonists Partial Agonist Agonist/Antagonist Antagonist 
Morphine and derivates 
Codeine 
Fentanyl 
Sulfentanil 
Alfentanil 
Remifentanil 
Meperidine 
Buprenorphine Nalbuphine 
Butorphanol 
Pentazocine 
Naloxone 
Naltrexone 
Table 2. 
In acute pain scenarios, most opioid-related adverse events are transient and tend to resolve 
with ongoing treatment. The common adverse events are nausea, vomiting, sedation, 
pruritus, and constipation. Patients recovery from abdominal and gynecological surgery are 
generally at risk for opioid-induced bowel dysfunction and ileus with recommendation that 
such therapy may be supplemented with stool softeners, bulk laxatives, and occasional 
enemas27.  
When using opioids for acute pain management it is recommended to have safety rules that 
must be applied mainly in high risk patients. Neonates, infants, and children are at risk of 
adverse effects of opioids, owing to pharmacokinetic and pharmacodynamic changes. 
Routine use of pulse oximetry is recommended in all children receiving opioids28.  
Elderly patients are particularly at risk, as a number of other susceptibility factors  
can co-exist. Renal insufficiency can result in clinically significant accumulation of  
www.intechopen.com
 
Postoperative Pain Management After Hysterectomy – A Simple Approach 275 
Opiates 
Morphine Standard of comparison of all opioid analgesics 
Moderate analgesic potency 
Slow onset to peak effect 
Intermediate duration of activity 
Dose dependent adverse effects 
Release of histamine which may precipitate hypotension and bronchospasm 
Increases smooth muscle tone which exacerbate biliary, tubular, and ureteral 
colic 
Oxycodone Semisynthetic mu receptor agonist 
High oral bioavailability 
Less sedation than equivalent doses of morphine 
Hydromorphone Semysinthetic mu selective opioid agonist 
Analgesic potency 5-6 times greater than morphine with a greater ability to 
penetrate the blood brain barrier 
Less histamine release 
Fentanyl Mu-specific opioid agonist related to meperidine 
Analgesic potency 35-60 times greater than morphine 
Rapid onset and variable dose-dependent duration of effect 
Rapidly penetrate blood brain barrier and bind opioid receptors in central 
nervous system 
Provide hemodynamic stability 
Major adverse effects include rapid and profound respiratory depression 
and chest wall rigidity 
Methadone Opioid agonist 
Analgesic potency 1.5-2 times greater than morphine 
Oral bioavailability greater than 80% 
Accumulates in tissues so analgesic duration and risk of overdosing may 
increase with doses 
Prolongation of QTc interval and may initiate or exacerbate torsades de 
pointes and Wolff-Parkinson-White syndrome 
Good choice for patients with highly opioid dependent disorders 
Meperidine Opioid agonist 
Analgesic potency one tenth that of morphine 
Produces smooth muscle relaxing effect 
Codeine Opiate-derived analgesic 
Analgesic potency one-third to one-fourth as potent as morphine 
High incidence of nausea and vomiting 
Tramadol Weak mu-receptor opioid agonist  
Also inhibits re-uptake of both 5-HT and noradrenaline and stimulates the 
presynaptic release of 5-HT 
Analgesic potency similar to codeine 
Not recommended for severe acute pain 
Sufentanil Synthetic mu-specific opioid agonist related to fentanyl 
Analgesic potency 500-700 times greater than morphine 
Rapid onset and dose dependent duration of effect 
Buprenorphine Partial agonist-type opioid  
Available in a sublingual formulation 
Table 3. 
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pharmacologically active opioid metabolites and prolonged narcosis; such patients must be 
monitored for signs of toxicity. To date, this effect has only been reported with codeine, 
morphine, and pethidine. Dextropropoxyphene is not recommended in renal insufficiency.29 
The use of oxygen supply, highly trained nurses, monitoring to avoid respiratory and 
cardiovascular adverse events is highly recommended.  
5.4 Patient control analgesia 
Patient control analgesia (PCA) is the standard technique for the management of moderate 
or severe postoperative pain. The concept of intravenous PCA is described as a technique 
that allows patients to self-administer intravenous opioids as required and dates back to the 
mid-1960s. Nowadays the drugs used in this kind of devices vary according to hospital 
facilities and clinician preferences. Opioids are the first line drugs used in PCA, however in 
many hospitals a combination of opioids and NSAIDs for background infusions with a extra 
shot at patient request are now used. Regular paracetamol and NSAIDs can be used 
simultaneously. Supplementary oxygen should be considered, particularly on the first and 
second postoperative nights. 
Over the years, further improvements were made to the design of PCA devices. These 
have resulted in increases in security and data output capacity, introduction of error 
reduction programs, and a choice of mains in battery power. In addition, a variety of 
disposable delivery systems are now available. Before PCA can be used safely and 
effectively it is mandatory to educate the patients, all medical and nursing staff involved 
in its utilization. 
5.5 Intravenous PCA 
Most authors use morphine as the opioid of choice beginning with a small dose (1mg of 
morphine) at patient request, with a lockout period (5 minutes) to prevent overdosing. 
However there are many side effects of morphine that has lead a vary of studies searching 
for the optimal opioid for PCA analgesia. Lenz et al. showed in their study that oxycodone 
was more potent than morphine for visceral pain relief but not for sedation in patients after 
laparoscopic hysterectomy30.  
For abdominal hysterectomies in a teaching hospital in Mexico City a combination of 
fentanyl (1mg) plus ketorolac (90-120mg of ketorolac) in a mix of 100cc of total volume is 
given to the patients at a rate of 0.4mcg/kg/hr of fentanyl with the same dose for patient 
request with a lockout of 30minutes16.  
5.6 Epidural analgesia 
Epidural analgesia provides excellent pain management after major surgery. It is only safe 
to use on wards with trained staff under pain service supervision. Usually, a combined 
local anesthetic and opiate infusion is used. These drugs act synergistically, but can be 
given separately. The level and density of block must be regularly assessed. Ideally, the 
local anesthetic will provide blockade of small nerve fibers (pain and temperature) but 
maintain fine sensation and motor power. The opiates augment the analgesic effect at 
spinal level. 
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The sympathetic blockade associated with local anesthetics can result in vasodilation and 
subsequent hypotension. The location of the epidural catheter placement affects the efficacy 
of epidural analgesia and influences patient outcomes. Epidural catheters should be inserted 
in a location congruent to the incisional dermatome. Discrepancy between epidural catheter 
insertion level and incision site may lead to an increased rate of side effects secondary to an 
increased infusion rate and increased volumes of local anesthetics used. Inadequate pain 
relief can lead to early termination of epidural analgesia and masking the potential 
beneficial effects of epidural analgesia31 
Side effects of epidural opiates include pruritus, nausea and vomiting, urinary retention, 
and respiratory depression. Continuous supplementary oxygen should be used. 
The choice of analgesic agents administered in the epidural space play a significant role in 
the achievement of optimal analgesia. The most common agents used are opioids and local 
anesthetics. Other agents include clonidine, neostigmine, adenosine, ketamine. 
Removal of epidural catheters may need to be timed to match a therapeutic trough after 
prophylactic heparin or low molecular weight heparin is given. 
5.7 Epidural PCA 
Two meta-analysis have concluded that IV PCA is less effective than continuous epidural 
and PCA-epidural analgesia.32, 33 
Local anesthetics are not widely used as the sole agent in postoperative epidural analgesia. 
To achieve effective analgesia using local anesthetics alone, patients will require higher 
concentrations of the drugs that could result in hypotension and motor block. Nevertheless, 
epidural of local anesthetics alone may be warranted in situations in which the side effects 
of opioids are troublesome to the patient.  
The most commonly used local anesthetics in epidural analgesic preparations are 
bupivacaine, ropivacaine and levobupivacaine. Nowadays for many clinicians ropivacaine 
is the local anesthetic of choice for background infusions because of their unique property of 
minimum motor blockade. Most authors recommend an infusion with a 1-2% concentration 
of ropivacaine at a 4-6ml/hr. An additional opioid could be used in the same mixture. 
5.8 Other pain management techniques 
This includes the use of non-opiate drugs such as clonidine or tramadol, continuous nerve 
blocks, and novel drugs used epidurally. The management of a surgical patient with 
coexisting substance abuse issues or chronic pain problems of any cause is complex and 
requires the early involvement of a pain specialist. 
5.9 Glucocorticoids for pain management 
Glucocorticoids have a number of beneficial properties in a surgical setting. In addition to 
being antiemetic, they are antiinflammatory, analgesic, antipyretic, and antiallergic34. 
Glucocorticoids exert their effects by binding to a glucocorticoid receptor (GR) localized in 
the cytoplasm of target cells. There is a single class of GR that binds glucocorticoids, with no 
evidence for subtypes of differing affinity in different tissues35. 
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Glucocorticoids may control inflammation by inhibiting many aspects of the inflammatory 
process through increasing the transcription of anti-inflammatory genes and decreasing the 
transcription of inflammatory genes.  
Glucocorticoids inhibit the transcription of several cytokines that are relevant in 
inflammatory diseases, including IL-1b, IL-2, IL-3, IL-6, IL-11, TNF-a, GM-CSF and 
chemokines that attract inflammatory cells to the site of inflammation, including IL8, 
RANTES, MCP-1, MCP-3, MCP-4, MIP-1a and eotaxin.  
The analgesic effect of glucocorticoids was first shown with betamethasone in patients 
undergoing third molar extraction36. A group of doctors from the Helsinki University 
Hospital chose to investigate the analgesic potency of different doses of dexamethasone for 
postoperative pain management of patients who underwent laparoscopic hysterectomy37. IV 
dexamethasone 15 mg before induction of anesthesia decreases the oxycodone consumption 
during the first 24 h after laparoscopic hysterectomy. During first 2 h after surgery, 
dexamethasone 10 mg reduces the oxycodone consumption as effectively as the 15 mg dose. 
The opioid-sparing potency of dexamethasone is dose dependent. The effect of the 5 mg 
dose on postoperative oxycodone consumption was negligible, whereas the 10 and 15 mg 
doses reduced oxycodone consumption during the first 2 h after surgery. 
There is also some studies that presumed the prolonged analgesic effect of non steroidal 
anti-inflammatory drugs with dexamethasone; a group of experts from Scandinavia, have 
demonstrated that the association of 16 mg of dexamethasone with rofecoxib has prolonged 
its analgesic effect38. It is also worth mentioning a cost related benefit of the use of 
dexamethasone. Compared to costs of multiple doses of non-steroidal antiinflammatory 
drugs used during and after this procedure sounds reasonable to use a single dose of 
dexamethasone in order to reduce consumption of analgesics. 
5.10 Adjuvants in anesthesia and postoperative pain 
A number of adjuvants have been added to the intrathecal local anaesthetics for 
supplementation of intraoperative anaesthesia and postoperative analgesia. They have 
advantages as they reduce the dose of local anaesthetic; provide long lasting postoperative 
analgesia with reduced incidence of central nervous system depression, motor effects or 
hypotension. 
Ketamine is an intravenous (IV) anesthetic with analgesic properties in subanesthetic doses, 
secondary to its action on the NMDA receptor. Several trials are investigating the use of 
low-dose ketamine for managing postoperative pain. The effect of adding ketamine to 
morphine for postoperative patient-controlled analgesia (PCA), compared with using 
morphine alone was investigated in six trials involving 330 patients. Only one trial in 
patients undergoing lumbar microdiscectomy39 showed a beneficial effect of adding 
ketamine. There were no analgesic effects of ketamine in the other five studies in patients 
undergoing abdominal surgery 41. Adverse effects including vivid dreams, hallucinations, 
dysphoria, and disorientation were increased in ketamine-treated patients in two studies. 
Dextromethorphan is a weak, noncompetitive NMDA antagonist that has been used as an 
antitussive agent. It has been shown to inhibit development of cutaneous secondary 
hyperalgesia in people after peripheral burn injury and to reduce temporal summation of 
pain40. Several studies investigated the effect of the perioperative administration of 
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dextromethorphan on acute postoperative pain. Opiate-related adverse effects were similar 
between patients who received dextromethorphan and control patients. Postoperative 
administration of IM dextromethorphan at a dose of 40 mg and oral dextromethorphan (200 
mg every 8 hours) also were associated with a significant reduction in postoperative opioid 
consumption41. 
Analgesic effect of intrathecal neostigmine is secondary to acetylcholine release in the spinal 
cord tissue42. During surgical stimuli, a pre-existent spinal cholinergic tonus is activated. 
Neostigmine, an anticholinsterase drug increases the concentration of acetylcholine in the 
cerebrospinal fluid and acetylcholine bioavailability at the cholinergic nerves within the 
spinal cord. The existence of a cholinergic system in the spinal dorsal horn involved in 
sensory transmission and modulation is supported by anatomical, pharmacological and 
electrophysiological studies. Electrophysiological studies have demonstrated that 
cholinergic receptor agonists produce inhibitory effects on spinal dorsal horn neurons, 
including spinothalamic tract neurons43. This suggests that a spinal cholinergic system plays 
an important inhibitory role in the modulation of nociceptive transmission. 
Nitric oxide (NO) was shown to be a central neurotransmitter and to act as a second 
messenger in the central nervous system. There are several reports of the relationship 
between NO and pain processing in the brain and the spinal cord. Acetylcholine and 
morphine induce analgesia via activation of the arginine-NO-cGMP pathway. Guanylate 
cyclase activity in the brain is markedly stimulated by NO, generated from L-arginine or 
provided through an exogenous source. The transdermal nitroglycerine patch has been 
related to NO formation during degradation of organic nitrates.  
There is a significant increase in postoperative analgesia when neostigmine is added to 
intrathecal bupivacaine in patients undergoing total abdominal hysterectomy. A 
combination of 5 mg/day transdermal nitroglycerine patch and intrathecal low dose 
neostigmine (5 mcg) resulted in an average of 10 hours of postoperative analgesia after total 
abdominal hysterectomy during bupivacaine spinal block, compared to 3.5 hours in the 
control group. Also the use of intrathecal neostigmine and transdermal nitroglycerine delays 
the first requirement of rescue analgesia by 6.5 hours. Transdermal nitroglycerine has been 
shown to increase the postoperative analgesia of intrathecal opioids44.  
6. Conclusions 
Recent developments in our understanding of incisional pain have highlighted the 
complexity of perioperative pain and the need for optimal management not only to provide 
rapid recovery but also to prevent long-term consequences. 
More than 100 NSAIDs are marketed or at an advance stage of development worldwide. 
There is no a single compound with proven efficacy better than other in the treatment of 
postoperative pain. The search for more efficacious and better-tolerated compounds is still 
being persued.  
Principles of safe IV treatment: 
- Acetaminophen or pure NSAIDs alone 
- Acetaminophen + NSAIDs 
- Weak opioid + acetaminophen or 
- Weak opioid + NSAIDs 
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